Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Intravenous (IV) Therapy and Vein Access Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Research Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Intravenous (IV) Therapy and Vein Access Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Infusion pumps
      • 1.3.3 Implantable Ports
      • 1.3.4 Intravenous Catheters
      • 1.3.5 Hypodermic Needles
      • 1.3.6 Other
    • 1.4 Market Segment by Application
      • 1.4.1 Global Intravenous (IV) Therapy and Vein Access Market Share by Application (2019-2025)
      • 1.4.2 Hospital
      • 1.4.3 Clinics
      • 1.4.4 Other
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Production and Capacity Analysis
      • 2.1.1 Global Intravenous (IV) Therapy and Vein Access Production Value 2014-2025
      • 2.1.2 Global Intravenous (IV) Therapy and Vein Access Production 2014-2025
      • 2.1.3 Global Intravenous (IV) Therapy and Vein Access Capacity 2014-2025
      • 2.1.4 Global Intravenous (IV) Therapy and Vein Access Marketing Pricing and Trends
    • 2.2 Key Producers Growth Rate (CAGR) 2019-2025
      • 2.2.1 Global Intravenous (IV) Therapy and Vein Access Market Size CAGR of Key Regions
      • 2.2.2 Global Intravenous (IV) Therapy and Vein Access Market Share of Key Regions
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Capacity and Production by Manufacturers
      • 3.1.1 Global Intravenous (IV) Therapy and Vein Access Capacity by Manufacturers
      • 3.1.2 Global Intravenous (IV) Therapy and Vein Access Production by Manufacturers
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Intravenous (IV) Therapy and Vein Access Revenue by Manufacturers (2014-2019)
      • 3.2.2 Intravenous (IV) Therapy and Vein Access Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Intravenous (IV) Therapy and Vein Access Market Concentration Ratio (CR5 and HHI)
    • 3.3 Intravenous (IV) Therapy and Vein Access Price by Manufacturers
    • 3.4 Key Manufacturers Intravenous (IV) Therapy and Vein Access Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Intravenous (IV) Therapy and Vein Access Market
    • 3.6 Key Manufacturers Intravenous (IV) Therapy and Vein Access Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Production and Production Value for Each Type
      • 4.1.1 Infusion pumps Production and Production Value (2014-2019)
      • 4.1.2 Implantable Ports Production and Production Value (2014-2019)
      • 4.1.3 Intravenous Catheters Production and Production Value (2014-2019)
      • 4.1.4 Hypodermic Needles Production and Production Value (2014-2019)
      • 4.1.5 Other Production and Production Value (2014-2019)
    • 4.2 Global Intravenous (IV) Therapy and Vein Access Production Market Share by Type
    • 4.3 Global Intravenous (IV) Therapy and Vein Access Production Value Market Share by Type
    • 4.4 Intravenous (IV) Therapy and Vein Access Ex-factory Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Intravenous (IV) Therapy and Vein Access Consumption by Application

    6 Production by Regions

    • 6.1 Global Intravenous (IV) Therapy and Vein Access Production (History Data) by Regions 2014-2019
    • 6.2 Global Intravenous (IV) Therapy and Vein Access Production Value (History Data) by Regions
    • 6.3 United States
      • 6.3.1 United States Intravenous (IV) Therapy and Vein Access Production Growth Rate 2014-2019
      • 6.3.2 United States Intravenous (IV) Therapy and Vein Access Production Value Growth Rate 2014-2019
      • 6.3.3 Key Players in United States
      • 6.3.4 United States Intravenous (IV) Therapy and Vein Access Import & Export
    • 6.4 European Union
      • 6.4.1 European Union Intravenous (IV) Therapy and Vein Access Production Growth Rate 2014-2019
      • 6.4.2 European Union Intravenous (IV) Therapy and Vein Access Production Value Growth Rate 2014-2019
      • 6.4.3 Key Players in European Union
      • 6.4.4 European Union Intravenous (IV) Therapy and Vein Access Import & Export
    • 6.5 China
      • 6.5.1 China Intravenous (IV) Therapy and Vein Access Production Growth Rate 2014-2019
      • 6.5.2 China Intravenous (IV) Therapy and Vein Access Production Value Growth Rate 2014-2019
      • 6.5.3 Key Players in China
      • 6.5.4 China Intravenous (IV) Therapy and Vein Access Import & Export
    • 6.6 Rest of World
      • 6.6.1 Japan
      • 6.6.2 Korea
      • 6.6.3 India
      • 6.6.4 Southeast Asia

    7 Intravenous (IV) Therapy and Vein Access Consumption by Regions

    • 7.1 Global Intravenous (IV) Therapy and Vein Access Consumption (History Data) by Regions
    • 7.2 United States
      • 7.2.1 United States Intravenous (IV) Therapy and Vein Access Consumption by Type
      • 7.2.2 United States Intravenous (IV) Therapy and Vein Access Consumption by Application
    • 7.3 European Union
      • 7.3.1 European Union Intravenous (IV) Therapy and Vein Access Consumption by Type
      • 7.3.2 European Union Intravenous (IV) Therapy and Vein Access Consumption by Application
    • 7.4 China
      • 7.4.1 China Intravenous (IV) Therapy and Vein Access Consumption by Type
      • 7.4.2 China Intravenous (IV) Therapy and Vein Access Consumption by Application
    • 7.5 Rest of World
      • 7.5.1 Rest of World Intravenous (IV) Therapy and Vein Access Consumption by Type
      • 7.5.2 Rest of World Intravenous (IV) Therapy and Vein Access Consumption by Application
      • 7.5.1 Japan
      • 7.5.2 Korea
      • 7.5.3 India
      • 7.5.4 Southeast Asia

    8 Company Profiles

    • 8.1 B. Braun
      • 8.1.1 B. Braun Company Details
      • 8.1.2 Company Description and Business Overview
      • 8.1.3 Production and Revenue of Intravenous (IV) Therapy and Vein Access
      • 8.1.4 Intravenous (IV) Therapy and Vein Access Product Introduction
      • 8.1.5 B. Braun Recent Development
    • 8.2 Baxter International
      • 8.2.1 Baxter International Company Details
      • 8.2.2 Company Description and Business Overview
      • 8.2.3 Production and Revenue of Intravenous (IV) Therapy and Vein Access
      • 8.2.4 Intravenous (IV) Therapy and Vein Access Product Introduction
      • 8.2.5 Baxter International Recent Development
    • 8.3 Becton Dickinson
      • 8.3.1 Becton Dickinson Company Details
      • 8.3.2 Company Description and Business Overview
      • 8.3.3 Production and Revenue of Intravenous (IV) Therapy and Vein Access
      • 8.3.4 Intravenous (IV) Therapy and Vein Access Product Introduction
      • 8.3.5 Becton Dickinson Recent Development
    • 8.4 C. R. Bard
      • 8.4.1 C. R. Bard Company Details
      • 8.4.2 Company Description and Business Overview
      • 8.4.3 Production and Revenue of Intravenous (IV) Therapy and Vein Access
      • 8.4.4 Intravenous (IV) Therapy and Vein Access Product Introduction
      • 8.4.5 C. R. Bard Recent Development
    • 8.5 Fresenius Kabi
      • 8.5.1 Fresenius Kabi Company Details
      • 8.5.2 Company Description and Business Overview
      • 8.5.3 Production and Revenue of Intravenous (IV) Therapy and Vein Access
      • 8.5.4 Intravenous (IV) Therapy and Vein Access Product Introduction
      • 8.5.5 Fresenius Kabi Recent Development
    • 8.6 Hospira(ICU Medical)
      • 8.6.1 Hospira(ICU Medical) Company Details
      • 8.6.2 Company Description and Business Overview
      • 8.6.3 Production and Revenue of Intravenous (IV) Therapy and Vein Access
      • 8.6.4 Intravenous (IV) Therapy and Vein Access Product Introduction
      • 8.6.5 Hospira(ICU Medical) Recent Development
    • 8.7 Medtronic
      • 8.7.1 Medtronic Company Details
      • 8.7.2 Company Description and Business Overview
      • 8.7.3 Production and Revenue of Intravenous (IV) Therapy and Vein Access
      • 8.7.4 Intravenous (IV) Therapy and Vein Access Product Introduction
      • 8.7.5 Medtronic Recent Development
    • 8.8 Smiths Group
      • 8.8.1 Smiths Group Company Details
      • 8.8.2 Company Description and Business Overview
      • 8.8.3 Production and Revenue of Intravenous (IV) Therapy and Vein Access
      • 8.8.4 Intravenous (IV) Therapy and Vein Access Product Introduction
      • 8.8.5 Smiths Group Recent Development
    • 8.9 Teleflex
      • 8.9.1 Teleflex Company Details
      • 8.9.2 Company Description and Business Overview
      • 8.9.3 Production and Revenue of Intravenous (IV) Therapy and Vein Access
      • 8.9.4 Intravenous (IV) Therapy and Vein Access Product Introduction
      • 8.9.5 Teleflex Recent Development

    9 Market Forecast

    • 9.1 Global Market Size Forecast
      • 9.1.1 Global Intravenous (IV) Therapy and Vein Access Capacity, Production Forecast 2019-2025
      • 9.1.2 Global Intravenous (IV) Therapy and Vein Access Production Value Forecast 2019-2025
    • 9.2 Market Forecast by Regions
      • 9.2.1 Global Intravenous (IV) Therapy and Vein Access Production and Value Forecast by Regions 2019-2025
      • 9.2.2 Global Intravenous (IV) Therapy and Vein Access Consumption Forecast by Regions 2019-2025
    • 9.3 United States
      • 9.3.1 Production and Value Forecast in United States
      • 9.3.2 Consumption Forecast in United States
    • 9.4 European Union
      • 9.4.1 Production and Value Forecast in European Union
      • 9.4.2 Consumption Forecast in European Union
    • 9.5 China
      • 9.5.1 Production and Value Forecast in China
      • 9.5.2 Consumption Forecast in China
    • 9.6 Rest of World
      • 9.6.1 Japan
      • 9.6.2 Korea
      • 9.6.3 India
      • 9.6.4 Southeast Asia
    • 9.7 Forecast by Type
      • 9.7.1 Global Intravenous (IV) Therapy and Vein Access Production Forecast by Type
      • 9.7.2 Global Intravenous (IV) Therapy and Vein Access Production Value Forecast by Type
    • 9.8 Consumption Forecast by Application

    10 Value Chain and Sales Channels Analysis

    • 10.1 Value Chain Analysis
    • 10.2 Sales Channels Analysis
      • 10.2.1 Intravenous (IV) Therapy and Vein Access Sales Channels
      • 10.2.2 Intravenous (IV) Therapy and Vein Access Distributors
    • 10.3 Intravenous (IV) Therapy and Vein Access Customers

    11 Opportunities & Challenges, Threat and Affecting Factors

    • 11.1 Market Opportunities
    • 11.2 Market Challenges
    • 11.3 Porter's Five Forces Analysis

    12 Key Findings

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
          • 13.1.1.1 Research Programs/Design
          • 13.1.1.2 Market Size Estimation
          • 13.1.1.3 Market Breakdown and Data Triangulation
        • 13.1.2 Data Source
          • 13.1.2.1 Secondary Sources
          • 13.1.2.2 Primary Sources
      • 13.2 Author Details

      IV therapy and vein access devices market is categorized into implantable ports, intravenous catheters, hypodermic needles, infusion pumps, and other products.
      In 2019, the market size of Intravenous (IV) Therapy and Vein Access is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Intravenous (IV) Therapy and Vein Access.

      This report studies the global market size of Intravenous (IV) Therapy and Vein Access, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Intravenous (IV) Therapy and Vein Access production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      B. Braun
      Baxter International
      Becton Dickinson
      C. R. Bard
      Fresenius Kabi
      Hospira(ICU Medical)
      Medtronic
      Smiths Group
      Teleflex

      Market Segment by Product Type
      Infusion pumps
      Implantable Ports
      Intravenous Catheters
      Hypodermic Needles
      Other

      Market Segment by Application
      Hospital
      Clinics
      Other

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Intravenous (IV) Therapy and Vein Access status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Intravenous (IV) Therapy and Vein Access manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Intravenous (IV) Therapy and Vein Access are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now